[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:merkel-cell-carcinoma:mrc1-wt-allele":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Merkel Cell Carcinoma","MRC1 wt Allele",3,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07197671","Y-NM600 in Patients Receiving Anti-PD-1 or Anti-PD-L1 for Metastatic Cancer",[12],"Phase 1","RECRUITING","2026-08-26T02:15:58.452248Z","2026-05-05T02:43:29.735881Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05086692","A Beta-only IL-2 ImmunoTherapY Study",[20],"Phase 1\u002FPhase 2","2026-08-26T02:18:31.164304Z","2026-05-05T02:35:31.708594Z",{"nct_id":24,"title":25,"phases":26,"status":28,"updated_at":29,"content_modified":30},"NCT03935893","Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers",[27],"Phase 2","ACTIVE_NOT_RECRUITING","2026-08-03T03:19:35.241322Z","2026-05-05T02:43:26.987294Z"]